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The relationship of hair glucocorticoid levels
to immunological and virological outcomes
in a large cohort of combination antiretroviral
therapy treated people living with HIV
Quan Zhang1,2*†, Xiaoming Li1, Shan Qiao1, Shuaifeng Liu3†, Yuejiao Zhou3 and Zhiyong Shen3*

Abstract
Background: Existing literature mostly investigated the relationship of acute or short-term glucocorticoid exposure
to HIV disease progression using cortisol levels in serum, saliva, or urine. Data are limited on the relationship of longterm glucocorticoid exposure to HIV disease progression. This study examined whether hair glucocorticoid levels,
novel retrospective indicators of long-term glucocorticoid exposure, are associated with two common indicators of
HIV disease progression (CD4 count and HIV viral load) among a large cohort of combination antiretroviral therapy
treated Chinese people living with HIV (PLHIV).
Methods: A total of 1198 treated PLHIV provided hair samples for glucocorticoid (cortisol and cortisone) assay and
completed a survey assessing sociodemographic, lifestyle, and HIV-related characteristics. Meanwhile, CD4 count and
HIV viral load were retrieved from their medical records. Spearman correlation was used to examine the associations
of hair cortisol and cortisone levels to continuous CD4 count and HIV viral load. Multivariate logistic regression was
used to predict CD4 count < 500 cells/mm3.
Results: Both hair cortisol and cortisone levels were negatively associated with CD4 count but not with HIV viral load.
The odds ratio for CD4 count < 500 cells/mm3 was 1.41 [95% CI 0.99–2.00] and 2.15 [95% CI 1.51–3.05] for those with
hair cortisol and cortisone levels in the highest quartile compared to the lowest when controlling for sociodemographic, lifestyle, HIV-related covariates, and HIV viral load.
Conclusion: Hair glucocorticoid levels were associated with CD4 count but not viral load in treated Chinese PLHIV.
Our data furtherly supported the hypothesis that elevated glucocorticoid levels are associated with the lower CD4
count.
Keywords: Hair cortisol, Hair cortisone, CD4 count, HIV viral load, People living with HIV
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Background
With the help of combination antiretroviral therapy
(cART), HIV has shifted from a terminal illness with
high mortality to chronic disease [1], and people living
with HIV (PLHIV) have a nearly normal life expectancy
when given access to adequate cART [2]. However,
HIV disease progression on an individual basis varies
widely. While the HIV disease progression is influenced
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by various factors, activation of the hypothalamic–
pituitary–adrenal (HPA) axis, resulting in elevated
glucocorticoid levels, has been proposed as one of the
critical pathways to hasten HIV disease progression.
Theoretically, high glucocorticoid levels could induce
T-lymphocyte production of cytokines, trigger the
destruction of CD4 T cell (CD4) through programmed
cell death and bolster HIV viral replication [3, 4].
Several studies have examined whether cortisol
(active glucocorticoid) levels are associated with indicators of HIV disease progression among PLHIV. However, the findings are inconsistent, with some studies
found that elevated cortisol levels were associated with
indicators of HIV disease progression [5–11], whereas
other studies suggested no such association [12–20].
Previous studies used acute or short-term cortisol levels in liquid biological samples (e.g., serum, saliva, or
urine). These measurements reflect cortisol levels of
that specific time window varying from a few minutes
(single-point blood and saliva sample) up to a maximum of 24 h (multi-point saliva and urine sample),
which may not well-match the etiology of chronic disease progression. In addition, cortisol levels in these
liquid biological samples showed significant circadian rhythm and were easily affected by state reactivity. Recently, several studies used cortisol levels in hair
among PLHIV [21–24]. In comparison with cortisol
levels in liquid biological samples, cortisol levels in hair
can better estimate long-term cortisol exposure (weeks
to months) [25]. To the best of our knowledge, only two
published studies reported additional data about the
relationship between hair cortisol levels and two common indicators of HIV disease progression (CD4 count
and HIV viral load), and a nonsignificant association
was found [21, 23]. The two previous studies are limited
in enrolling small sample size participants and not considering some potential factors related to hair cortisol
levels (e.g., hair washing). Thus, a study of hair cortisol levels and HIV disease progression in a large cohort
of PLHIV is warranted, further considering potential
confounders.
Recently, hair cortisone levels have been served as a
useful additional biomarker for assessing long-term
glucocorticoid exposure. As well known, circulating cortisol levels are dynamically regulated partially
through the activity of the 11β hydroxysteroid dehydrogenase (11β-HSD) enzyme, where cortisol is converted
to cortisone by the activity of 11β-HSD type 2 enzyme,
and cortisone can be regenerated from cortisol by the
activity of 11β-HSD type1 enzyme [26]. Therefore, cortisol and cortisone could regulate physiological and
psychological responses together [27, 28]. However,
it is unknown about hair cortisone levels in PLHIV
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and their relationship with indicators of HIV disease
progression.
Accordingly, to extend knowledge on the associations
of long-term glucocorticoid levels with HIV disease progression, we assessed hair cortisol and cortisone levels
and two common indicators of HIV disease progression
(CD4 count and HIV viral load) in a large cohort of cART
treated Chinese PLHIV in Guangxi, China. We aimed
to examine whether hair cortisol and cortisone levels
were associated with those indicators of HIV disease
progression when controlling for potential confounders,
including sociodemographic, lifestyle, and HIV-related
characteristics.

Methods
Participants

Participants were recruited from November 2017 to
February 2018 as part of a longitudinal HIV stigma project, which aimed to investigate the effect of HIV-related
stigma on clinical outcomes in Guangxi, China [29, 30].
In collaboration with the Guangxi center for disease control and prevention (CDC), PLHIV, who aged 18 years,
willing to provide hair samples and retrieve virologic
and immunological outcomes from their medical record,
were eligible for participation. PLHIV with any of the
following characteristics were excluded: (1) linguistic,
mental or physical inability to respond to assessment
questions; (2) opportunistic infections or endocrine diseases (e.g., Cushing’s syndrome); (3) currently taking hormonal medications (e.g., oral contraceptive) or known
history of illegal drug use; (4) chemical hair treated (e.g.,
dyed, permed, or bleached) or scalp hair in the posterior
vertex was less than 1 cm.
Medical staff or HIV case managers at the study sites
referred potential participants to the research team
members. PLHIV were checked for eligibility, informed
of the study’s benefits and risks, and invited to the study
when they finished their routine visit. Research team
members were local CDC staff or health care workers in
the HIV clinics who had received intensive training on
research ethics and interview skills with PLHIV before
the field data and hair specimen collection. Finally, a total
of 1198 PLHIV participated in this study.
Hair and data collection

Hair samples were cut from the posterior vertex region
as close as possible to the scalp following a standard
protocol [31, 32] in private rooms of local CDC or HIV
clinics. The hair thatch then was completely enclosed by
a piece of foil, and a small label indicating the study ID
number was placed over the distal end of the hair thatch.
Then, the interviewer-administered questionnaire was
used for the collection of sociodemographic and lifestyle
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information. Each participant received compensation for
their time spent to respond to the questionnaire and to
provide hair samples with a value equal to $5.00 (≈ 35
Chinese Yuan) after finishing the survey.
Hair cortisol and cortisone

The proximal 1 cm of hair segments (approximately
reflecting the last month of accumulative cortisol and
cortisone levels) was cut finely with scissors, and 20 mg
processed and analyzed using liquid chromatographytandem mass spectrometry (LC/MS/MS) followed the
protocol described by Gao and colleagues [33]. The
method showed excellent linearity (R2 > 0.99) in the range
of 0.5–1250 pg/mg for both cortisol and cortisone, the
limits of detection and quantitation at 0.2 pg/mg and at
0.5 pg/mg for both cortisol and cortisone, respectively.
Intra-day and inter-day percentage coefficients of variation were less than 5% at standard concentrations of 1.25,
25, and 250 pg/mg, and recovery ranged between 95 and
107% for both cortisol and cortisone.
CD4 count and HIV viral load

CD4 count and HIV viral load data were extracted from
their clinical records after their routine visit. Given
that CD4 count and HIV viral load data are generally
skewed, CD4 count was dichotomized as ≥ 500 cells/
mm3 vs. < 500 cells/mm3 because the low limit of CD4
count is 500 cells/mm3 in healthy adults. HIV viral load
was dichotomized as ≥ 200 copies/ml vs. < 200 copies/ml
because the “Undetectable = Untransmittable” initiative
defined undetectable viral load as viral load less than 200
copies/ml that cannot sexually transmit HIV to others
[34].
Sociodemographic, lifestyle, and other HIV‑related
characteristics

Participants provided information on their sociodemographic and lifestyle characteristics that might have a
potential influence on hair cortisol and cortisone levels
[35–37], including age, gender, ethnicity, marital status,
education level, employment status, monthly household
income level, height, weight, smoking status, drinking status and frequency of hair washing. Body Mass
Index (BMI) was calculated using an established formula
BMI = weight (kg)/ [height (m)]2 based on weight and
height for each participant.
Years of HIV diagnosis, current cART status (first-line
vs. second-line), and years of current cART were also
extracted from their clinical records. cART adherence
(≥ 95% vs. < 95%) was measured using the single-item
question: “In last month, how many days were you able to
take your medications exactly as prescribed?” Adherence
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was calculated by dividing the reported number of days
by 30 days [38].
Statistical analyses

Of the 1198 PLHIV, one participant was excluded due
to insufficient weight of hair samples (less than 20 mg)
for cortisol assaying, and six participants were excluded
because of unavailable hair cortisol levels due to the analysis mistake, leaving an effective sample of 1191 participants for analysis.
As indicated by the Kolmogorov–Smirnov test, continuous hair cortisol, hair cortisone, CD4 count, or HIV
viral load was not the normal distribution, then Spearman’s correlation was used to examine the associations
of continuous hair cortisol and hair cortisone levels
with continuous CD4 count and HIV viral load. Logistic
regression models were used to estimate the association
of hair cortisol and cortisone levels with CD4 count < 500
cells/mm3 but not HIV viral load ≥ 200 copies/ml
because the number of viremic participants is very low
(n = 35, 2.9%). Hair cortisol and cortisone levels quartiles
were calculated, and the second, third, and fourth quartiles were contrasted with the first quartile as the reference category. Crude odds ratios (cOR) and their 95%
confidence interval (95%CI) were reported for univariate
analysis. Adjusted odds ratios (aOR) and their 95% CI
were derived from multivariate analyses after controlling
for sociodemographic, lifestyle, and HIV-related characteristics, including HIV viral load. All analyses were
performed using SPSS for Windows, version 26 (IBM,
Chicago, Illinois).

Results
Of the 1191 participants with a median age of 38 years
(Table 1), 64.3% were male, 65.1% were Han ethnicity,
56.6% were married, 81.6% were employed, 67% were
never smoking, 50.3% were never drinking, 88.2% were
washing their hair less than four times per week, 79.7%
were receiving the first-line cART, and 92.8% reported
optimal cART adherence (≥ 95%), 2.9% had HIV viral
load ≥ 200 copies/ml. Most of the participants had low
income and education levels, with 60.3% reporting a
monthly household income of less than 3000 Chinese
Yuan (or approximately $460 during the survey) and
60.2% reporting not finishing junior high school. The
median BMI was 21.29 kg/m2. The median years of HIV
diagnosis and years of cART were 5.33 and 4.42 years,
respectively.
The median hair cortisol levels were 28.17 pg/mg and
hair cortisone levels were 27.45 pg/mg. As presented in
Table 2, spearman’s correlation revealed that hair cortisol
levels and hair cortisone levels were positively correlated
(r = 0.226, p < 0.001); hair cortisol and cortisone levels
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Table 1 Distribution of variables in the participants (n = 1191)
Variables

Age, years

n (%)/ median (range)
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Table 2 Correlation between hair cortisol, hair cortisone, CD4
count, and HIV viral load
Hair cortisol Hair
cortisone

38 (18–60)

18–30

197 (16.5%)

31–40

493 (41.4%)

Hair cortisol

–

41–50

323 (27.1%)

0.226***

51–60

178 (14.9)

Hair cortisone
CD4 count

− 0.129***

Gender
Male

766 (64.3%)

Female

425 (35.7%)

HIV Viral load 0.025

CD4 count HIV viral load

–
− 0.148***

− 0.025

–
0.070*

–

* < 0.05; *** < 0.001

Ethnicity
Han

775 (65.1%)

No-Han

416 (34.9%)

Marital status
Married

674 (56.6%)

Others

517 (43.4%)

Education levels
≤ 9 years

> 9 years

717 (60.2%)
474 (39.8%)

Employment status
Employed

972 (81.6%)

Unemployed

219 (18.4%)

Monthly income level
≥ 3000 Yuan
< 3000 Yuan
BMI, kg/m2

473 (39.7%)
718 (60.3%)
21.29 (13.11–31.55)

Smoking
Yes

393 (33.0%)

No

798 (67.0%)

Drinking
Yes

592 (49.7%)

No

599 (50.3%)

Frequency of hair washing, times/week
≥ 4 times/week
< 4 times/week

Years of HIV diagnosis

141 (11.8%)
1050 (88.2%)
5.33 (0.25–14.67)

cART status
First-line cART

949 (79.7%)

Second-line cART

242 (20.3%)

Years of cART

4.42 (0.25–13.00)

Self-reported adherence in the past month
≥ 95%
< 95%

1105 (92.8%)
86 (7.2%)

Hair cortisol, pg/mg

28.17 (0.20–3587.90)

Hair cortisone, pg/mg

27.45 (0.20–1893.17)

CD4 count, cells/mm3

470 (8–1685)

≥ 500 cells/mm3

536 (45.0%)

< 500 cells/mm3

655 (55.0%)

HIV viral load, copies/ml
≥ 200 copies/ml
< 200 copies/ml

35 (2.9%)
1156 (97.1%)

BMI body mass index, cART combination antiretroviral therapy

were negatively correlated with CD4 count (r = − 0.129,
p < 0.001 for hair cortisol levels; r = − 0.148, p < 0.001
for hair cortisone levels); neither hair cortisol nor cortisone levels were correlated with HIV viral load (r = 0.025,
p = 0.395 for hair cortisol levels; r = − 0.025, p = 0.396 for
hair cortisone levels).
Of 1191 PLHIV, 55.0% had CD4 count < 500 cells/mm3
(see Table1). The results of logistic regression models of
CD4 count < 500 cells/mm3 are presented in Table 3. The
cORs were 1.77 [95% CI 1.28–2.45] and 2.39 [95% CI
1.72–3.33] for those with hair cortisol and cortisone levels in the highest quartile compared to the lowest quartile
in univariate analysis. The aORs were 1.41 [95% CI 0.99–
2.00] and 2.15 [95% CI 1.51–3.05] for those with hair
cortisol and cortisone levels in the highest quartile compared to the lowest quartile when controlling for sociodemographic, lifestyle, and HIV-related characteristics.

Discussion
The central question investigated in this study was
whether hair cortisol and cortisone levels, novel retrospective indicators of long-term glucocorticoid exposure,
were associated with two common indicators of HIV disease progression (CD4 count and HIV viral load) among
a large cohort of Chinese PLHIV. We found that hair glucocorticoid levels were negatively associated with CD4
count but not HIV viral load.
Notably, we found that hair glucocorticoid levels were
negatively associated with CD4 count and the aORs for
CD4 count < 500 cells/mm3 were 1.41 times and 2.15
times for those with hair cortisol and cortisone levels
in the highest quartile compared to the lowest quartile.
The result regarding the significant association between
hair cortisol levels and CD4 count was in line with part
of previous studies that also reported a negative association between CD4 count and cortisol levels in plasma
and saliva [5–9] but differed from the results from some
published studies in which a nonsignificant association
was reported by using serum cortisol levels [15, 18–20],
urinary cortisol levels [12, 13, 16, 17], or hair cortisol
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Table 3 Logistic regression models of CD4 count < 500 cells/mm3
n (%)

Univariate

Multivariate

cOR (95% CI)

p

aOR(95% CI)

p

Hair cortisol
First quartile

146 (49.0%)

1 [reference]

–

1 [reference]

–

Second quartile

157 (52.7%)

1.18 (0.85–1.62)

0.326

1.14 (0.82–1.60)

0.444

Third quartile

166 (55.7%)

1.33 (0.96–1.83)

0.085

1.10 (0.78–1.55)

0.596

Fourth quartile

186 (62.6%)

1.77 (1.28–2.45)

< 0.001

1.41 (0.99–2.00)

0.055

18–30

–

–

–

1 [reference]

–

31–40

–

–

–

1.08 (0.74–1.58)

0.684

41–50

–

–

–

1.87(1.21–2.88)

0.005

51–60

–

–

–

2.05(1.26–3.32)

0.004

–

–

–

0.65 (0.47–0.90)

0.009

Age

Gender
Ethnicity

–

–

–

0.72 (0.56–0.93)

0.01

Marital status

–

–

–

0.99 (0.76–1.30)

0.961

Education levels

–

–

–

0.59 (0.45–0.78)

< .001

Employment status

–

–

–

0.91 (0.66–1.25)

0.547

Monthly income levels

–

–

–

0.98 (0.76–1.27)

0.874

BMI

–

–

–

0.95 (0.91–0.99)

0.017

Smoking

–

–

–

0.87 (0.65–1.18)

0.369

Drinking

–

–

–

0.83 (0.63–1.09)

0.172

Frequency of hair washing

–

–

–

0.84 (0.57–1.24)

0.381

Years of HIV diagnosis

–

–

–

0.90(0.81–0.97)

0.01

cART status

–

–

–

1.08 (0.79–1.47)

0.627

Years of cART

–

–

–

1.04 (0.95–1.14)

0.408

Self-reported adherence

–

–

–

1.26 (0.79–2.01)

0.323

HIV viral load

–

–

–

2.03 (0.93–4.42)

0.076

First quartile

132 (44.4%)

1 [reference]

–

1 [reference]

–

Second quartile

162 (54.2%)

1.48 (1.07–2.04)

0.018

1.52 (1.09–2.13)

0.014

Third quartile

165 (55.4%)

1.55 (1.12–2.14)

0.008

1.50 (1.07–2.12)

0.020

Fourth quartile

195 (65.7%)

2.39 (1.72–3.33)

< 0.001

2.15 (1.51–3.05)

< 0.001

18–30

–

–

–

1 [reference]

–

31–40

–

–

–

1.10 (0.75–1.61)

0.631

41–50

–

–

–

1.83(1.18–2.82)

0.007

51–60

–

–

–

1.98(1.21–3.23)

0.006

–

–

–

0.62 (0.45–0.85)

0.003

Hair cortisone

Age

Gender
Ethnicity

–

–

–

0.73 (0.57–0.94)

0.016

Marital status

–

–

–

1.00 (0.77–1.31)

0.992

Education levels

–

–

–

0.61 (0.46–0.80)

< .001

Employment status

–

–

–

0.89 (0.64–1.23)

0.469

Monthly income levels

–

–

–

1.01 (0.78–1.31)

0.934

BMI

–

–

–

0.95 (0.91–0.99)

0.009

Smoking

–

–

–

0.85 (0.63–1.15)

0.287

Drinking

–

–

–

0.85 (0.65–1.12)

0.244

Frequency of hair washing

–

–

–

0.84 (0.57–1.24)

0.37

Years of HIV diagnosis

–

–

–

0.88 (0.81–0.96)

0.006

cART status

–

–

–

1.10 (0.80–0.96)

0.554

Years of cART

–

–

–

1.04 (0.95–1.14)

0.403

Self-reported adherence

–

–

–

1.25 (0.78–2.00)

0.349

HIV viral load

–

–

–

2.11 (0.96–4.63)

0.063

CI confidence interval, cOR crude odds ratio, aOR adjusted odds ratio, Adjusted for age, gender, ethnicity, marital status, education level, employment status, monthly
income levels, BMI, smoking, drinking, frequency of hair washing, years of HIV diagnosis, cART status, years of cART, self-reported adherence, and HIV viral load in the
multivariate model
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levels [21]. Interestingly, we found stronger associations
between hair cortisone levels and CD4 count than hair
cortisol levels did, which was in line with some previous
studies that also reported stronger associations between
hair cortisone levels and variables studied than hair cortisol levels did, including Parkinson’s disease [39], Cushing’s syndrome [40], cardiometabolic variables [41, 42],
and stress-related variables [39, 43]. In addition, we
found hair cortisone levels and hair cortisol levels were
positively correlated, which is similar to the findings in
previous studies [39, 41, 42, 44–46]. Previous studies
indicated that salivary cortisone levels were more closely
associated with unbound, biologically active cortisol levels than total cortisol levels [26], and hair cortisone levels
were significantly associated with salivary cortisone levels [45, 47]. Therefore, hair cortisone levels may provide
a valuable surrogate for assessing long-term free cortisol levels. Our findings with large sample size and better
controlling potential confounders could further support
the hypothesis that elevated glucocorticoid levels are
associated with CD4 declining and provide implications
for future research to consider both hair cortisol and cortisone levels to reflect the long-term glucocorticoid exposure. Furthermore, previous studies indicated linkages
among gut dysbiosis, leaky gut, CD4 count, and cortisone
in the HIV-related research field [48–51]. Future research
could explore those linkages using hair levels of cortisol
and cortisone.
We found that neither hair cortisol levels nor hair cortisone levels were associated with HIV viral load. Our
results regarding the nonsignificant association between
hair glucocorticoid levels and HIV viral load were generally in line with previous cross-sectional studies by
employing hair cortisol levels [21, 23], serum cortisol
levels [14, 52], and urinary cortisol levels [16]. However,
one longitudinal study reported that urinary cortisol levels could predict a faster increase in HIV viral load over
4 years [12]. Thus, further research is needed to explore
this association with a longitudinal design.
While our study does hold some strengths, including enrolling a large cohort of PLHIV as participants,
controlling various confounders, and using 1-cm hair
to measure the past month’s glucocorticoid exposure,
several limitations need to be acknowledged. First, the
current study was based on cross-sectional data. Our
findings cannot draw causal inferences. Future research
should examine the predictive value of hair glucocorticoid levels for incident HIV disease progression using
longitudinal designs. Second, several other glucocorticoid measurements (e.g., cortisol awakening response
and diurnal slope) in blood or saliva [8, 53], cortisol
regulations (e.g., the sensitivity of the glucocorticoid
receptor) [54–56], and other indicators of HIV disease
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progression (e.g., HIV DNA levels, CD8 and CD16)
should be considered in future research in that they
may yield robust conclusions. Third, because all participants are from Guangxi, China, these findings may not
be generalizable to other PLHIV settings. Fourth, while
data were not available in the current study on some
other potential factors (e.g., physical exercise, depression, and some other medications) that might influence hair cortisol levels, CD4 count, and HIV viral load
[35, 57], those factors should be considered in future
research.

Conclusion
In summary, this study found that hair cortisol and cortisone levels were negatively associated with CD4 count,
but not HIV viral load, in a large cohort of Chinese
PLHIV. Our data furtherly supported the hypothesis that
elevated cortisol levels are associated with lower CD4
counts. Future work will focus on the longitudinal relationship of cortisol and cortisone levels in various biological samples to indicators of HIV disease progression.
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